IP Library Assignment 054775/0546
Patent Assignment
Reel/Frame 054775/0546

Security Interest

Recorded: 2020-11-19 Pages: 9
Assignor
TRIZELL LTD.
Executed: 2009-01-06
Assignee
PHARMACEUTICAL PATENT ATTORNEYS, LLC
55 MADISON AVENUE,, 4TH FLOOR, MORRISTOWN, NEW JERSEY, 07960-7397
Covered Properties (47)
Nadofaragene Radenovec for Superficial Bladder Cancer
Application: 62/790,524 →
Method to Curtail the Progression of Non-Muscle Invasive Bladder Cancer To Muscle-Invasive Cancer
Application: 16/702,782 →
Publication: US 2020/0222477
Gene Therapy Vector Contamination Assay
Application: 16/426,124 →
Publication: US 2019/0292609
CDKN2a Companion Diagnostic for Bladder Cancer Interferon Therapy
Application: 62/597,473 →
Adherent Cell Culture Substrate Sampling Device
Application: 15/763,123 →
Publication: US 2020/0172847
Anti-Angiogenic Gene Therapy With Soluble VEGF Receptors -1, -2 and -3 Together With Paclitaxel Prolongs Survival Of Mice With Human Ovarian Carcinoma
Application: 13/969,763 →
Publication: US 2014/0057851
Antiangiogenic Gene Therapy with Soluble VEGF-receptors -1, -2 and -3 Together with Paclitaxel Prolongs Survival of Mice with Human Ovarian Carcinoma
Application: 61/692,828 →
Anti-Angiogenic Gene Therapy Kit
Application: 16/364,284 →
Publication: US 2019/0275106
Large scale manufacturing of viral vectors in fixed-bed bioreactor using plasmid transfection and special tubing system
Application: 62/322,651 →
Fixed-Bed Bioreactor With Constant-Flow Pump / Tubing System
Application: 15/579,208 →
Publication: US 2019/0031998
Aseptic Bioreactor Sampling System
Application: 16/357,532 →
Publication: US 2019/0218495
Large-Scale PEI-Mediated Plasmid Transfection
Application: 15/777,228 →
Publication: US 2020/0165557
Interferon Therapy
Application: 62/295,268 →
Interferon Therapy
Application: 15/430,456 →
Publication: US 2017/0232071
Interferon Therapy
Application: 16/280,174 →
Publication: US 2019/0255153
Viral Vector Stabilization
Application: 62/322,452 →
Viral Vector Stabilization
Application: 16/931,600 →
Publication: US 2020/0352861
Viral Vector Stabilization
Application: 16/931,615 →
Publication: US 2020/0352862
Viral Vector Assay and Vector
Application: 62/218,810 →
Viral Vector Assay and Vector
Application: 15/754,598 →
Publication: US 2019/0338307
Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time
Application: 16/299,221 →
Publication: US 2019/0276846
Vegf-D Mutants and Their Use
Patent: 8,188,039 →
Application: 12/599,294 →
Publication: US 2011/0144013
Production of Lentiviral Vectors
Application: 12/522,646 →
Publication: US 2010/0003746
Nucleic Acid Application Primers
Application: 16/681,964 →
Publication: US 2020/0071725
Use of Inhibitors of the Renin-Angiotensin System
Patent: 7,071,183 →
Application: 10/206,659 →
Publication: US 2002/0187939
Use of Inhibitors of the Renin-Angiotensin System
Patent: 8,604,070 →
Application: 13/360,895 →
Publication: US 2012/0178784
Use of Inhibitors of the Renin-Angiotensin System
Patent: 8,003,679 →
Application: 11/441,648 →
Publication: US 2006/0217429
Use of Inhibitors of the Renin-Angiotensin System
Patent: 7,998,953 →
Application: 11/119,181 →
Publication: US 2005/0192327
PILOT AND FEASIBILITY CLINICAL TRIAL EVALUATING IMMUNO-GENE THERAPY OF MALIGNANT PLEURAL MESOTHELIOMA (MPM) USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA (Ad.hIFN-ALPHA2b) IN COMBINATION WITH HIGH-DOSE CELECOXIB AND SYSTEMIC CHEMOTHERAPY
Application: 62/304,233 →
Immuno-Gene Combination Therapy
Application: 15/672,330 →
Publication: US 2019/0060313
Immuno-Gene Combination Therapy
Application: 16/268,548 →
Publication: US 2019/0167690
Gene Therapy For Mesothelioma
Application: 16/456,066 →
Publication: US 2019/0314378
Gene Therapy For Mesothelioma
Application: 16/601,698 →
Publication: US 2021/0106674
CDKN2a Companion Diagnostic for Bladder Cancer Interferon Therapy
Application: 16/458,275 →
Publication: US 2020/0360499
Use of Inhibitors of the Renin-Angiotensin System
Patent: 7,071,183 →
Application: 10/206,659 →
Publication: US 2002/0187939
Use of Inhibitors of the Renin-Angiotensin System
Patent: 7,998,953 →
Application: 11/119,181 →
Publication: US 2005/0192327
Use of Inhibitors of the Renin-Angiotensin System
Patent: 8,003,679 →
Application: 11/441,648 →
Publication: US 2006/0217429
Use of Inhibitors of the Renin-Angiotensin System
Patent: 8,604,070 →
Application: 13/360,895 →
Publication: US 2012/0178784
Vegf-D Mutants and Their Use
Patent: 8,188,039 →
Application: 12/599,294 →
Publication: US 2011/0144013
Interferon Therapy
Application: 15/430,456 →
Publication: US 2017/0232071
Nucleic Acid Application Primers
Application: 16/681,964 →
Publication: US 2020/0071725
Method to Curtail the Progression of Non-Muscle Invasive Bladder Cancer to Muscle-Invasive Cancer
CDKN2A Companion Diagnostic for Bladder Cancer Interferon Therapy
Ultra-High-Precision Viral Vector Assay
Improved Interferon Therapy
Viral Vector Stabilization
Seeding an Adherent Cell Bioreactor with Non-Adherent Cells Increases Seeding Density Limit and Reduces Required Expansion Time
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 19, 2009
From: LESCH, HANNA P.; AIRENNE, KARI J.; YIA-HERTTUALA, SEPPO
To: ARK THERAPEUTICS LTD.
Reel/Frame 023115/0455 →
Assignment of Assignor's Interest May 26, 2010
From: TOIVANEN, PYRY; AIRENNE, KARI JUHANI; YLA-HERTTUALA, SEPPO
To: ARK THERAPEUTICS LTD
Reel/Frame 024441/0534 →
Assignment of Assignor's Interest Nov 20, 2015
From: PARKER, NIGEL; LESCH, HANNA; MYKKANEN, JENNI; PAULO, SARA
To: FINVECTOR VISION THERAPIES LTD.
Reel/Frame 037098/0067 →
Change of Name Sep 12, 2016
From: FINVECTOR VISION THERAPIES LTD
To: TRIZELL LTD
Reel/Frame 039704/0762 →
Assignment of Assignor's Interest Jan 9, 2017
From: AIRENNE, KARI J.; LESCH, HANNA P.; YLA-HERTTUALA, SEPPO
To: ARK THERAPEUTICS LTD.
Reel/Frame 040901/0241 →
Change of Name Jan 9, 2017
From: ARK THERAPEUTICS LTD.
To: FINVECTOR VISION THERAPIES LTD
Reel/Frame 041304/0595 →
Change of Name Jan 9, 2017
From: FINVECTOR VISION THERAPIES LTD
To: TRIZELL LTD
Reel/Frame 040901/0335 →
Assignment of Assignor's Interest Apr 22, 2017
From: VALONEN, PIIA; LESCH, HANNA; MULLER, ACHIM; RASANEN, EVA
To: TRIZELL LIMITED
Reel/Frame 042121/0377 →
Assignment of Assignor's Interest Apr 27, 2017
From: LIPPONEN, EEVI; LESCH, HANNA; VALKAMA, ANNIINA; MALINEN, JOONAS
To: TRIZELL LIMITED
Reel/Frame 042348/0184 →
Assignment of Assignor's Interest Jun 1, 2017
From: PARKER, NIGEL, PH.D, DR.; SHAW, ROBERT, PH.D, DR; HASSINEN, MINNA, PH.D, DR.
To: TRIZELL LIMITED
Reel/Frame 042563/0338 →
Assignment of Assignor's Interest Jun 19, 2017
From: PARKER, NIGEL
To: FKD THERAPIES LIMITED
Reel/Frame 042741/0627 →
Assignment of Assignor's Interest Jun 29, 2017
From: LIPPONEN, EEVI; LESCH, HANNA P.; VALKAMA, ANNIINA; MALINEN, JOONAS
To: TRIZELL LTD
Reel/Frame 043032/0224 →
Assignment of Assignor's Interest Jun 29, 2017
From: VALONEN, PIIA KRISTIINA; LESCH, HANNA P; MULLER, ACHIM; RASANEN, EVA KRISTIINA
To: TRIZELL LTD
Reel/Frame 042855/0923 →
Assignment of Assignor's Interest Dec 3, 2017
From: VALONEN, PIIA KRISTIINA; LESCH, HANNA P.; MULLER, ACHIM; RASANEN, EVA KRISTIINA
To: TRIZELL LTD
Reel/Frame 044281/0962 →
Assignment of Assignor's Interest Dec 12, 2017
From: DINNEY, COLIN P.
To: FKD THERAPIES LIMITED
Reel/Frame 044363/0941 →
Assignment of Assignor's Interest Feb 26, 2018
From: PARKER, NIGEL; LESCH, HANNA P; MYKKANEN, JENNI; PAULO, SARA
To: FINVECTOR VISION THERAPIES LTD.
Reel/Frame 045031/0322 →
Change of Name Feb 26, 2018
From: FINVECTOR VISION THERAPIES LTD.
To: TRIZELL LTD.
Reel/Frame 045031/0343 →
Assignment of Assignor's Interest Aug 8, 2018
From: WKD HOLDING OY
To: TRIZELL LTD.
Reel/Frame 046585/0156 →
Assignment of Assignor's Interest Aug 8, 2018
From: YLA-HERTTUALA, SEPPO; PARKER, NIGEL; SOPO, MINNA; SALLINEN, HANNA
To: WKD HOLDING OY
Reel/Frame 046748/0608 →
Assignment of Assignor's Interest Sep 5, 2018
From: PARKER, NIGEL
To: TRIZELL LIMITED
Reel/Frame 046783/0952 →
Assignment of Assignor's Interest Sep 5, 2018
From: FKD THERAPIES LIMITED
To: TRIZELL LIMITED
Reel/Frame 046783/0945 →
Assignment of Assignor's Interest Oct 22, 2018
From: FKD THERAPIES LIMITED
To: TRIZELL LIMITED
Reel/Frame 047254/0868 →
Assignment of Assignor's Interest Oct 22, 2018
From: PARKER, NIGEL
To: TRIZELL LIMITED
Reel/Frame 047254/0791 →
Assignment of Assignor's Interest Dec 11, 2018
From: FKD THERAPIES LIMITED
To: TRIZELL LIMITED
Reel/Frame 047735/0412 →
Assignment of Assignor's Interest Feb 20, 2019
From: FKD THERAPIES LIMITED
To: TRIZELL LIMITED
Reel/Frame 048380/0822 →